ClinicalTrials.Veeva

Menu

Very Low Nicotine Cigarettes in Smokers With Schizophrenia

Brown University logo

Brown University

Status and phase

Completed
Phase 2

Conditions

Tobacco Dependence

Treatments

Other: standard nicotine content cigarettes
Other: Very low nicotine content cigarettes

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT02019459
5U54DA031659-03

Details and patient eligibility

About

Smokers with serious mental illness including those with schizophrenia and bipolar disorder infrequently attempt and attain sustained smoking abstinence and have a 25-year shorter lifespan due to smoking-related illness. This study will examine whether reducing the nicotine content of cigarettes to non-addicting levels is a viable method of reducing smoking in smokers with serious mental illness. Smokers will be randomized to one of two experimental conditions: 1) very low nicotine content (VLNC) cigarettes or 2) normal nicotine content (NNC) cigarettes. Participants will be assessed for patterns of tobacco use, biomarkers of exposure, subjective responses (e.g., satisfaction, craving, withdrawal symptoms), psychiatric symptoms, cognitive performance, smoking cue reactivity and smoking topography.

Enrollment

58 patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18-70
  • Schizophrenia, schizoaffective disorder or bipolar disorder
  • Smoke an average of at least 10 cigarettes per day for at least 1 year
  • Breath carbon monoxide (CO) levels >8 ppm (if ≤ 8 ppm, then nicotine (NicAlert) Strip > 2)

Exclusion criteria

  • Pregnant or nursing
  • Seeking treatment for smoking
  • Medical contraindications

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

58 participants in 2 patient groups

0.8 mg nicotine with 10.5 mg tar
Active Comparator group
Description:
SPECTRUM Cigarette: 0.8 (±0.15) mg nicotine yield with 9 (±1.5) mg tar (standard nicotine and tar yields of commercially-available cigarettes; control condition)
Treatment:
Other: standard nicotine content cigarettes
0.03 mg nicotine with 9 mg tar
Experimental group
Description:
SPECTRUM Cigarette: 0.03 mg (± 0.02) nicotine yield with 9 mg (± 1.5) tar
Treatment:
Other: Very low nicotine content cigarettes

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems